Total Payments
$7,958
2024 Payments
$645.84
Companies
19
Transactions
217
Medicare Patients
795
Medicare Billing
$33,883
Payment Breakdown by Category
Food & Beverage$6,052 (76.1%)
Travel$1,806 (22.7%)
Education$99.99 (1.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,052 | 210 | 76.1% |
| Travel and Lodging | $1,806 | 6 | 22.7% |
| Education | $99.99 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $2,097 | 13 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,649 | 54 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,059 | 55 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $691.62 | 30 | $0 (2024) |
| Genentech USA, Inc. | $522.37 | 13 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $384.82 | 10 | $0 (2024) |
| Medtronic, Inc. | $342.96 | 4 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $333.05 | 13 | $0 (2024) |
| Cerus Corporation | $156.03 | 2 | $0 (2017) |
| GENZYME CORPORATION | $136.34 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $645.84 | 16 | Medtronic, Inc. ($132.50) |
| 2023 | $856.22 | 14 | AstraZeneca Pharmaceuticals LP ($328.43) |
| 2022 | $671.87 | 24 | AstraZeneca Pharmaceuticals LP ($196.08) |
| 2021 | $712.61 | 38 | GlaxoSmithKline, LLC. ($187.25) |
| 2020 | $659.37 | 33 | GlaxoSmithKline, LLC. ($348.26) |
| 2019 | $1,065 | 39 | AstraZeneca Pharmaceuticals LP ($278.73) |
| 2018 | $2,403 | 26 | Merck Sharp & Dohme Corporation ($1,716) |
| 2017 | $943.67 | 27 | AstraZeneca Pharmaceuticals LP ($246.02) |
All Payment Transactions
217 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $53.54 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: Immunology | ||||||
| 08/29/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.95 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/28/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: VACCINE | ||||||
| 08/07/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $124.85 | General |
| Category: Cardiovascular | ||||||
| 06/13/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: Inflammation | ||||||
| 06/12/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Respiratory | ||||||
| 05/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: RESPIRATORY | ||||||
| 05/14/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $106.19 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 03/05/2024 | Medtronic, Inc. | AXIUM PRIMETM (Device) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: Intrasaccular | ||||||
| 02/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: RESPIRATORY | ||||||
| 02/27/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $87.45 | General |
| 02/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: RESPIRATORY | ||||||
| 12/27/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Travel and Lodging | Cash or cash equivalent | $142.00 | General |
| Category: Respiratory | ||||||
| 10/26/2023 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $115.10 | General |
| Category: Transcatheter Valve Systems | ||||||
| 10/18/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Travel and Lodging | Cash or cash equivalent | $142.00 | General |
| Category: Respiratory | ||||||
| 10/11/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2023 | PFIZER INC. | COMIRNATY (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: VACCINES | ||||||
| 09/11/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: RESPIRATORY | ||||||
| 05/24/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Respiratory | ||||||
| 05/17/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: IMMUNOLOGY | ||||||
| 04/12/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 14 | 30 | $2,783 | $1,910 |
| 2022 | 1 | 14 | 25 | $2,319 | $1,713 |
| 2021 | 9 | 717 | 738 | $28,914 | $25,681 |
| 2020 | 3 | 50 | 65 | $6,475 | $4,580 |
Total Patients
795
Total Services
858
Medicare Billing
$33,883
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 30 | $2,783 | $1,910 | 68.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 25 | $2,319 | $1,713 | 73.8% |
| 0002A | Adm sarscov2 30mcg/0.3ml 2nd | Office | 2021 | 245 | 245 | $9,855 | $9,831 | 99.8% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 141 | 141 | $5,685 | $5,685 | 100.0% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 244 | 245 | $6,941 | $5,644 | 81.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 35 | $3,214 | $2,152 | 67.0% |
| 94726 | Determination of lung volumes using plethysmography | Office | 2021 | 15 | 15 | $836.46 | $582.43 | 69.6% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 12 | 12 | $726.35 | $581.04 | 80.0% |
| 94727 | Determination of lung volumes using gas dilution or washout | Office | 2021 | 15 | 15 | $673.68 | $533.30 | 79.2% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 15 | 15 | $724.39 | $464.74 | 64.2% |
| 94664 | Demonstration and/or evaluation of patient use of aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure breathing (ippb) device | Office | 2021 | 15 | 15 | $258.31 | $206.59 | 80.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 15 | 16 | $2,906 | $2,319 | 79.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 24 | 38 | $2,902 | $1,802 | 62.1% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2020 | 11 | 11 | $667.15 | $458.58 | 68.7% |
About Dr. Edgardo Cartagena Ayala, M.D
Dr. Edgardo Cartagena Ayala, M.D is a Pulmonary Disease healthcare provider based in San Juan, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/19/2007. The National Provider Identifier (NPI) number assigned to this provider is 1033262555.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edgardo Cartagena Ayala, M.D has received a total of $7,958 in payments from pharmaceutical and medical device companies, with $645.84 received in 2024. These payments were reported across 217 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($6,052).
As a Medicare-enrolled provider, Cartagena Ayala has provided services to 795 Medicare beneficiaries, totaling 858 services with total Medicare billing of $33,883. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location San Juan, PR
- Active Since 01/19/2007
- Last Updated 10/07/2010
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1033262555
Products in Payments
- MK-1242 (Drug) $1,716
- TRELEGY ELLIPTA (Drug) $692.16
- FASENRA (Biological) $599.16
- ELIQUIS (Drug) $564.30
- FASENRA (Drug) $469.48
- STIOLTO RESPIMAT (Drug) $425.33
- Esbriet (Biological) $354.37
- SYMBICORT (Drug) $326.58
- XARELTO (Drug) $313.95
- NUCALA (Biological) $166.96
- INTERCEPT BLOOD SYSTEM (Device) $156.03
- TEZSPIRE (Biological) $130.18
- BEVESPI AEROSPHERE (Drug) $115.83
- COREVALVE EVOLUT R (Device) $115.10
- STIOLTO (Drug) $109.51
- LINQ II (Device) $106.19
- ACTHAR (Biological) $99.99
- ANORO ELLIPTA (Drug) $98.63
- SOLITAIRE X (Device) $95.36
- DUPIXENT (Biological) $88.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in San Juan
Dr. Rafael Franjul Juliao, M.d, M.D
Pulmonary Disease — Payments: $27,437
Pulmonary Disease $27,437
Dr. Daphne Delgado, M.d, M.D
Pulmonary Disease — Payments: $11,197
Pulmonary Disease $11,197
Maria Betancourt Quiles, M.d, M.D
Pulmonary Disease — Payments: $7,543
Pulmonary Disease $7,543
Pedro Monroig Quiles, M.d, M.D
Pulmonary Disease — Payments: $6,338
Pulmonary Disease $6,338
Edgar Rodriguez Gonzalez, M.d, M.D
Pulmonary Disease — Payments: $5,923
Pulmonary Disease $5,923
Ramon Flores, M.d, M.D
Pulmonary Disease — Payments: $5,070
Pulmonary Disease $5,070